|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-7
|
|
pubmed:abstractText |
Clotting factor products have been safe for HIV since 1985, and for hepatitis C since 1992. Few studies have reported on mortality in the total population of hemophilia patients after the period of risk of viral infection transmission.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
510-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16460432-Adolescent,
pubmed-meshheading:16460432-Adult,
pubmed-meshheading:16460432-Aged,
pubmed-meshheading:16460432-Aged, 80 and over,
pubmed-meshheading:16460432-Cause of Death,
pubmed-meshheading:16460432-Child,
pubmed-meshheading:16460432-Child, Preschool,
pubmed-meshheading:16460432-HIV Infections,
pubmed-meshheading:16460432-Hemophilia A,
pubmed-meshheading:16460432-Hepatitis C,
pubmed-meshheading:16460432-Humans,
pubmed-meshheading:16460432-Infant,
pubmed-meshheading:16460432-Infant, Newborn,
pubmed-meshheading:16460432-Life Expectancy,
pubmed-meshheading:16460432-Male,
pubmed-meshheading:16460432-Middle Aged,
pubmed-meshheading:16460432-Netherlands,
pubmed-meshheading:16460432-Prospective Studies,
pubmed-meshheading:16460432-Severity of Illness Index
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.
|
|
pubmed:affiliation |
Leiden University Medical Center, Clinical Epidemiology, Leiden, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
